A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age

Clinical trial NCT04264156 · TERMINATED

Trial details

NCT number: NCT04264156
Sponsor: Windtree Therapeutics
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Distress Syndrome, Newborn

Start date: 2020-04-18
Primary completion: 2021-01-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.